In the present study, scopolamine increased the concentration of caspases 3 and 9, two significant contributors to apoptosis, in both the hippocampus and prefrontal cortex of the negative control group, similar to the results of Demirci et al. [56] with scopolamine-induced dementia in aged rats. This evidence concerns the gene CASP3 and dementia.